| 臺北醫學大學 |
2014 |
Anti-cancer effects of CME-1, a novel polysaccharide, purified from the mycelia of Cordyceps sinensis against B16-F10 melanoma cells
|
Jayakumar, T;Chiu, CC;Wang, SH;Chou, DS;Huang, YK;Sheu, JR |
| 中國醫藥大學 |
2013-07-04 |
Anti-Cancer Effects of Coptis chinensis and Evodia rutaecarpa in HepG2 Cells and in an Orthotopic Intrahepatic Xenograft Model
|
江素瑛(Su-yin Chiang);周順頂; ( Ming-tsung Lai);(Kuen-yuh Wu);項千芸(Chien-Yun Hsiang);侯庭鏞(Tin-Yun Ho)* |
| 國立屏東大學 |
2011 |
Anti-Cancer Effects of Protein Extracts from Calvatia lilacina, Pleurotus ostreatus and Volvariella volvacea
|
張雯惠;Wu, Jin-Yi;Chen, Chi-Hung;Chung, King-Thom;Liu, Yi-Wen;Lu, Fung-Jou;1, Ching-Hsein Chen |
| 國家衛生研究院 |
2018-08-15 |
Anti-cancer effects of radix angelica sinensis (danggui) and n-butylidenephthalide on gastric cancer: Implications for redd1 activation and mtor inhibition
|
Liao, KF;Chiu, TL;Huang, SY;Hsieh, TF;Chang, SF;Ruan, JW;Chen, SP;Pang, CY;Chiu, SC |
| 中國醫藥大學 |
2013-03-17 |
Anti-cancer effects of the novel curcumin nanoparticles: Induction of cell apoptosis through the caspase- and mitochondrial-dependent signaling pathways in human osteogenic sarcoma cell
|
彭淑芬(Shu-Fen Peng);(HSI-CHENG CHIEN);鍾景光(Jing-Gung Chung);楊家欣(Yang Jai-Sing)* |
| 國立臺灣大學 |
2014 |
Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer
|
Lin, Kai-Wei; Huang, A-Mei; Lin, Chi-Chen; Chang, Chia-Che; Hsu, Wei-Chi; Hour, Tzyh-Chyuan; Pu, Yeong-Shiau; Lin, Chun-Nan; 蒲永孝 |
| 臺大學術典藏 |
2021-02-02T00:46:21Z |
Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer
|
Lin K.-W.;Huang A.-M.;Lin C.-C.;Chang C.-C.;Hsu W.-C.;Hour T.-C.;Yeong-Shiau Pu;Lin C.-N.; Lin K.-W.; Huang A.-M.; Lin C.-C.; Chang C.-C.; Hsu W.-C.; Hour T.-C.; YEONG-SHIAU PU; Lin C.-N. |
| 高雄醫學大學 |
2007 |
Anti-cancer mechanisms of ursolic acid
|
鄭琪云;呂美津;李建志;林逸翔;張芳榮;黃旭霖;吳永昌 |
| 輔英科技大學 |
2018-02-01 |
Anti-Cancerous Effect of Inonotus taiwanensis Polysaccharide Extract on Human Acute Monocytic Leukemia Cells through ROS-Independent Intrinsic Mitochondrial Pathway
|
Chao, Tsai Ling;Wang, Ting Yin;Lee, Chin Huei;Yiin, Shuenn Jiun;Ho, Chun Te;Wu, Sheng Hua;You, Huey Ling;Chern, Chi-Liang |
| 中山醫學大學 |
2015 |
Anti-cancerous effects of Wasabia japonica extract in Hep3B liver cancer cells via ROS accumulation, DNA damage and p73-mediated apoptosis
|
Wu, Shu-Huan; Chyau, Charng-Cherng; Chen, Jing-Hsien; Tu, Shu-Fen; Lin, Hui-Hsuan; Chou, Fen-Pi |
| 國立臺灣大學 |
2007 |
Anti-Carbohydrate Antibodies Elicited by Polyvalent Display on a Viral Scaffold
|
Kaltgrad, Eiton; Gupta, Sayam Sen; Punna, Sreenivas; Huang, Cheng-Yuan; Chang, Aileen; Wong, Chi-Huey; Finn, M. G.; Blixt, Ola |
| 中山醫學大學 |
2000 |
Anti-cardiolipin antibodies in autoimmune thyroid diseases
|
徐再靜;蔡嘉哲 |
| 臺北醫學大學 |
2002 |
Anti-caries Effect of Polyphenol Containing Milk
|
李勝揚; 林哲堂; Chang W-Y; Wang C-Y; Guo B-R; Lo Y-Y; Lin C-Y; Lee S-Y |
| 臺北醫學大學 |
2002-12 |
Anti-caries Effect of Polyphenol Containing Milk
|
Wei-Jen Chang;Cheng-Yi Wang;Bay-Rong Guo;Yi Jun Lo;Che-Tong Lin;Sheng-Yang Lee |
| 臺北醫學大學 |
2014 |
Anti-CCP antibody in a patient with generalized discoid lupus erythematosus, vasculitis and acute interstitial lung disease but not rheumatoid arthritis
|
YT, Lin;TH, Tsai |
| 臺北醫學大學 |
2014 |
Anti-CCP antibody in a patient with generalized discoid lupus erythematosus, vasculitis and acute interstitial lung disease but not rheumatoid arthritis
|
Lin, YT;Tsai, TH |
| 臺北醫學大學 |
2014 |
Anti-CD20 as the B cell targeting agent in a combined therapy to modulate anti-factor VIII responses in hemophilia A inhibitor mice
|
Liu, Chao Lien;Ye, Peiqing;Lin, Jacqueline;Che'Butts, rie L.;Miao, Carol H. |
| 臺大學術典藏 |
2018-09-10T18:05:16Z |
Anti-CD20 therapy and pauci-immune crescentic glomerulonephritis
|
Shu, K.-H. and Chiang, W.-C. and Chiu, Y.-L.; WEN-CHIH CHIANG |
| 臺大學術典藏 |
2020-12-24T08:38:21Z |
Anti-CD20 therapy and pauci-immune crescentic glomerulonephritis
|
Chiu Y.-L.; WEN-CHIH CHIANG; Shu K.-H.; Shu K.-H.;Wen-Chih Chiang;Chiu Y.-L. |
| 國立臺灣大學 |
2016 |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chang, Ming-Cheng; Chen, Yu-Li; Chiang, Ying-Cheng; Cheng, Ya-Jung; Jen, Yu-Wei; Chen, Chi-An; Cheng, Wen-Fang; Sun, Wei-Zen; 鄭文芳; 孫維仁; 陳祈安; 江盈澄; 鄭雅蓉 |
| 臺大學術典藏 |
2018-09-10T15:39:08Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
CHI-AN CHEN; Chang, M.-C.;Chen, Y.-L.;Chiang, Y.-C.;Cheng, Y.-J.;Jen, Y.-W.;Chen, C.-A.;Cheng, W.-F.;Sun, W.-Z. |
| 臺大學術典藏 |
2016 |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; CHI-AN CHEN; Cheng W.-F.; Sun W.-Z. |
| 臺大學術典藏 |
2020-02-06T05:21:55Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; WEN-FANG CHENG; Sun W.-Z.; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; WEN-FANG CHENG; Sun W.-Z.; Sun W.-Z.;WEN-FANG CHENG;Chen C.-A.;Jen Y.-W.;Cheng Y.-J.;Chiang Y.-C.;Chen Y.-L.;Chang M.-C.; Chang M.-C. |
| 臺大學術典藏 |
2020-02-14T02:49:44Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; WEN-FANG CHENG; Sun W.-Z. |
| 臺大學術典藏 |
2020-02-14T08:50:32Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chang M.-C; Chen Y.-L; YING-CHENG CHIANG; Cheng Y.-J; Jen Y.-W; Chen C.-A; Cheng W.-F; Sun W.-Z. |
| 臺大學術典藏 |
2020-05-24T06:00:17Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chang M.-C.; YU-LI CHEN; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; Cheng W.-F.; Sun W.-Z. |
| 臺大學術典藏 |
2021-02-04T02:39:54Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chang M.-C.;Yu-Li Chen;Chiang Y.-C.;Cheng Y.-J.;Jen Y.-W.;Chen C.-A.;Cheng W.-F.;Sun W.-Z.; Chang M.-C.; YU-LI CHEN; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; Cheng W.-F.; Sun W.-Z. |
| 臺大學術典藏 |
2018-09-10T15:39:08Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine.
|
Ming-Cheng Chang, Yu-Li Chen, Ying-Cheng Chiang, Ya-Jung Cheng, Yu-Wei Jen, Chi-An Chen, Wen-Fang Cheng, Wei-Zen Sun; CHI-AN CHEN |
| 國立臺灣大學 |
2006 |
Anti-Cd45 Antibody Enhances Lipoxygenase Pathway of Human Naive Mononuclear Cells and Cyclooxygenase Pathway of Neutrophils
|
吳政翰; 謝松洲; 余幸司; 李光倫; 呂明錡; 蔡長佑; 余家利; WU, CHENG-HAN; HSIEH, SONG-CHOU; YU, HSIN-SU; LEE, KUANG-LUN; LU, MING-CHI; TSAI, C-Y; YU, CHIA-LI |
| 臺大學術典藏 |
2021-01-15T02:46:35Z |
Anti-CD45 antibody enhances lipoxygenase pathway of human naïve mononuclear cells and cyclooxygenase pathway of neutrophils
|
Wu C.-H.; SONG-CHOU HSIEH; Yu H.-S.; Lee K.-J.; Lu M.-C.; Tsai C.-Y.; Yu C.-L. |
| 臺大學術典藏 |
2022-02-10T06:48:32Z |
Anti-CD45 antibody enhances lipoxygenase pathway of human naïve mononuclear cells and cyclooxygenase pathway of neutrophils
|
Wu, C-H; Hsieh, S-C; Yu, H-S; KO-JEN LI; Lu, M-C; Tsai, C-Y; Yu, C-L |
| 臺大學術典藏 |
2021-01-27T01:38:17Z |
Anti-CD45 antibody enhances lipoxygenase pathway of human naïve mononuclear cells and cyclooxygenase pathway of neutrophils
|
Wu C.-H.;Hsieh S.-C.;Yu H.-S.;Lee K.-J.;Lu M.-C.;Tsai C.-Y.;Chia-Li Yu; Wu C.-H.; Hsieh S.-C.; Yu H.-S.; Lee K.-J.; Lu M.-C.; Tsai C.-Y.; CHIA-LI YU |
| 國立臺灣大學 |
2006 |
Anti-CD45 antibody enhances lipoxygenase pathway of human naive mononuclear cells and cyclooxygenase pathway of neutrophils.
|
Wu, CH; Hsieh, SC; Yu, HS; Lee, KJ; Lu, MC; Yu, CL. |
| 高雄醫學大學 |
2002 |
Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-a in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56ICK tyrosine kinase
|
余家利;余幸司;孫光蕙;謝松洲;蔡昌友; Yu, CL;Yu, HS;Sun, KH;Hsieh, SC;Tsai , CY |
| 國立臺灣大學 |
2002 |
Anti-Cd45 Isoform Antibodies Enhance Phagocytosis and Gene Expression of Il-8 and Tnf-Alpha in Human Neutrophils by Differential Suppression on Protein Tyrosine Phosphorylation and P56(Lck) Tyrosine Kinase
|
余家利; 謝松洲; YU, CHIA-LI; HSIEH, SONG-CHOU |
| 臺大學術典藏 |
2021-01-15T02:46:40Z |
Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-α in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase
|
Yu C.-L.; Yu H.-S.; Sun K.-H.; SONG-CHOU HSIEH; Tsai C.-Y. |
| 臺大學術典藏 |
2021-01-27T01:38:24Z |
Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-α in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase
|
Chia-Li Yu;Yu H.-S.;Sun K.-H.;Hsieh S.-C.;Tsai C.-Y.; CHIA-LI YU; Yu H.-S.; Sun K.-H.; Hsieh S.-C.; Tsai C.-Y. |
| 國立臺灣師範大學 |
2015-06-30T09:22:40Z |
Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivo
|
Huang, Kai-Wen; Chieh, Jen-Jie; Lin, In-Tsang; Horng, Herng-Er; Yang, Hong-Chang; Hong, Chin-Yih |
| 國立臺灣大學 |
2013 |
Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivo
|
Huang, Kai-Wen; Chieh, Jen-Jie; Lin, In-Tsang; Horng, Herng-Er; Yang, Hong-Chang; Hong, Chin-Yih; 黃凱文 |
| 國立成功大學 |
2018 |
Anti-cell proliferation effect of naphthoquinone dimers isolated from Plumbago zeylanica
|
Ito, C.;Matsui, T.;Takano, M.;Wu, T.-S.;Itoigawa, M. |
| 臺大學術典藏 |
2021-01-29T01:45:09Z |
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway
|
CHIEH-YU SHEN; Li, Ko-Jen; Lai, Pei-Hsuan; Yu, Chia-Li; Hsieh, Song-Chou |
| 臺大學術典藏 |
2022-02-09T02:42:41Z |
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway
|
CHIEH-YU SHEN; Li, Ko-Jen; Lai, Pei-Hsuan; Yu, Chia-Li; Hsieh, Song-Chou |
| 臺大學術典藏 |
2022-02-09T08:57:21Z |
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway
|
Shen, Chieh-Yu; KO-JEN LI; Lai, Pei-Hsuan; Yu, Chia-Li; Hsieh, Song-Chou |
| 臺大學術典藏 |
2021-01-15T02:46:18Z |
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud’s phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway
|
Shen C.-Y.; Li K.-J.; Lai P.-H.; Yu C.-L.; SONG-CHOU HSIEH |
| 臺大學術典藏 |
2021-01-27T01:37:58Z |
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud’s phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway
|
Shen C.-Y.;Li K.-J.;Lai P.-H.;Chia-Li Yu;Hsieh S.-C.; Shen C.-Y.; Li K.-J.; Lai P.-H.; CHIA-LI YU; Hsieh S.-C. |
| 臺大學術典藏 |
2022-01-25T08:15:23Z |
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud’s phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway
|
Shen C.-Y.; KO-JEN LI; Lai P.-H.; Yu C.-L.; Hsieh S.-C. |
| 臺大學術典藏 |
2021-02-01T00:48:53Z |
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud’s phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway
|
Shen C.-Y.; KO-JEN LI; Lai P.-H.; Yu C.-L.; Hsieh S.-C. |
| 中山醫學大學 |
2006 |
Anti-CENP-H antibodies in patients with Sjogren's syndrome.
|
Hsu, TC; Chang, CH; Lin, MC; Liu, ST; Yen, TJ; Tsay, GJ |
| 中山醫學大學 |
2002 |
Anti-centromere and anti-CENP-H antibodies in patients with rheumatic diseases
|
徐再靜;蔡嘉哲 |
| 中山醫學大學 |
2002 |
Anti-centromere and anti-CENP-H antibodies in patients with rheumatic diseases
|
劉光耀 |
